Quest Introduces Myeloma Test That Eliminates the Need for Bone Marrow Biopsies
The flow cytometry assay costs a fraction of traditional invasive bone marrow testing
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
ClearNote Health Launches Early Detection Test for Pancreatic Cancer
The test offers a 76 percent sensitivity to detection of stage 1 and stage 2 pancreatic cancers
Turning Physics into a Diagnostic Signal for Bladder Cancer
A physics-based urine test shows early promise in detecting bladder cancer recurrence without invasive procedures
Raising Urinary Tract Infection Threshold Cuts Unnecessary Antibiotic Use, Without Harming Patients
From - Diagnostic Testing & Emerging Technologies
Raising the laboratory threshold for identifying potential urinary tract infections (UTIs) may prevent…
Top 4 trends shaping the healthcare industry
By Leora Borgenicht bio
Before the healthcare industry can ambitiously transform to offer more accurate and personalized patient care, certain stepping stones must…
Researchers Find Marker That May Aid Diagnosis of Erectile Dysfunction
From - Diagnostic Testing & Emerging Technologies
The neutrophil-lymphocyte ratio (NLR) may be a marker to aid in diagnosing erectile dysfunction (ED), according to…
Consumers Interested in Raw Genetic Data, Third Party Interpretation Tools
...
Already a member? Log in here
Search Intensifies for Markers for Prosthetic Joint Infection
...
Already a member? Log in here
HCV Testing Uptake “Limited” Even Among Baby Boomers
From - Diagnostic Testing & Emerging Technologies
Only one in six baby boomers report having been tested for hepatitis C virus (HCV)< despite recommendations for…
Rule-In Using High-Sensitivity Cardiac Troponin May Misdiagnose Heart Attacks
From - Diagnostic Testing & Emerging Technologies
One in 20 patients without clinical suspicion of acute myocardial infarction has a high sensitivity cardiac troponin I (hs-cTnI) level greater than…
Partnerships, IT Solutions Improve Infectious Disease Diagnostic Stewardship
From - Diagnostic Testing & Emerging Technologies
Appropriate use of testing is becoming a greater challenge, given the growing number of available diagnostic tests and their increasing complexity&…
HPV DNA from Oral Rinse Samples May Be Prognostic Marker for Head, Neck Cancer
From - Diagnostic Testing & Emerging Technologies
Samples collected from a mouth rinse can detect human papillomavirus (HPV) DNA. These easily collected samples might provide important monitoring information for…
Improved Accuracy of Point-of-Care HbA1c Tests May Expand Access to Testing
From - Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration-cleared POC Afinion HbA1c Dx test (Alere Technologies a subsidiary of Abbott Laboratories) is accurate and…
